Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - 21 CFR Parts 807, 868, 870, 872, 874, 876, 878, 880, 882, 884, 886, and 892
          - [Docket No. 2006N-0335]

# ACTION:

Direct final rule; withdrawal.

# SUMMARY:

                        The Food and Drug Administration (FDA) published a direct final rule that appeared in the                         **Federal Register**                         of September 25, 2006 (71 FR 55729), that would have amended certain classification regulations for reprocessed single-use devices (SUDs) whose exemption from premarket notification (510(k)) requirements have been terminated and other reprocessed SUDs already subject to premarket notification for which validation data, as specified under the Medical Device User Fee and Modernization Act of 2002, are necessary in a 510(k). FDA stated in the direct final rule that, if it received a significant adverse comment by December 11, 2006, FDA would publish a notice of withdrawal.  FDA received two comments and considers at least one of these comments a significant adverse comment and, therefore, is withdrawing the direct final rule.  Accordingly, the agency will consider the comments received under our usual procedures for notice and comment in connection with the notice of proposed rulemaking that was published in the                         **Federal Register**                         of September 25, 2006 (71 FR 55748) as a companion to the direct final rule.                    

# DATES:

The direct final rule published at 71 FR 55729 on September 25, 2006, is withdrawn as of January 12, 2007.

# FOR FURTHER INFORMATION CONTACT:

Heather S. Rosecrans, Center for Devices and Radiological Health (HFZ-404), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-4040.

# 

Authority:  Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, the direct final rule published on September 25, 2006 (71 FR 55729), is withdrawn.

Dated: January 9, 2007.

Jeffrey Shuren,

Assistant Commissioner for Policy.

[FR Doc. 07-105 Filed 1-9-07; 2:49 pm]

BILLING CODE 4160-01-S